These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8449901)

  • 1. Mechanism-based design of prolactin receptor antagonists.
    Fuh G; Colosi P; Wood WI; Wells JA
    J Biol Chem; 1993 Mar; 268(8):5376-81. PubMed ID: 8449901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a second receptor binding site on human prolactin.
    Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA
    J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.
    Fuh G; Wells JA
    J Biol Chem; 1995 Jun; 270(22):13133-7. PubMed ID: 7768908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis for growth hormone-receptor interactions.
    Wells JA; Cunningham BC; Fuh G; Lowman HB; Bass SH; Mulkerrin MG; Ultsch M; deVos AM
    Recent Prog Horm Res; 1993; 48():253-75. PubMed ID: 8441850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF; Tan D; Walker AM; Chen WY
    Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of receptor-specific variants of human growth hormone.
    Cunningham BC; Wells JA
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3407-11. PubMed ID: 2014261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding sites for prolactin and growth hormone in the adult rabbit lung.
    Amit T; Barkey RJ; Guy J; Youdim MB
    Mol Cell Endocrinol; 1987 Jan; 49(1):17-24. PubMed ID: 3556748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-ray structure of a growth hormone-prolactin receptor complex.
    Somers W; Ultsch M; De Vos AM; Kossiakoff AA
    Nature; 1994 Dec; 372(6505):478-81. PubMed ID: 7984244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor.
    Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T
    Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human growth hormone (hGH) antagonist G120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor.
    Mode A; Tollet P; Wells T; Carmignac DF; Clark RG; Chen WY; Kopchick JJ; Robinson IC
    Endocrinology; 1996 Feb; 137(2):447-54. PubMed ID: 8593788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC; Brooks CL
    Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin (PRL) receptor induction in cultured rat hepatocytes: dual regulation by PRL and growth hormone.
    Barash I; Cromlish W; Posner BI
    Endocrinology; 1988 Mar; 122(3):1151-8. PubMed ID: 3342748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.
    Bustamante JJ; Grigorian AL; Muñoz J; Aguilar RM; Treviño LR; Martinez AO; Haro LS
    Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
    Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
    Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone.
    Ray J; Okamura H; Kelly PA; Cooke NE; Liebhaber SA
    J Biol Chem; 1990 May; 265(14):7939-44. PubMed ID: 2335510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling of rabbit prolactin hormone complexed with its receptor.
    Halaby D; Thoreau E; Djiane J; Mornon JP
    Proteins; 1997 Mar; 27(3):459-68. PubMed ID: 9094747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering human prolactin to bind to the human growth hormone receptor.
    Cunningham BC; Henner DJ; Wells JA
    Science; 1990 Mar; 247(4949 Pt 1):1461-5. PubMed ID: 2321008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay.
    Goffin V; Kinet S; Ferrag F; Binart N; Martial JA; Kelly PA
    J Biol Chem; 1996 Jul; 271(28):16573-9. PubMed ID: 8663214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two specific prolactin binding sites on Nb2 rat lymphoma cells.
    Rillema JA; Lawson DM
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):75-9. PubMed ID: 8115353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of potent antagonists to the human growth hormone receptor.
    Fuh G; Cunningham BC; Fukunaga R; Nagata S; Goeddel DV; Wells JA
    Science; 1992 Jun; 256(5064):1677-80. PubMed ID: 1535167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.